Arylsulfatase A deficiency (also known as metachromatic leukodystrophy or MLD) is characterized by three clinical subtypes: late-infantile MLD. La leucodistrofia metacromática es una enfermedad progresiva hereditaria y neurodegenerativa. Un paciente que sufre de esta enfermedad representa. Request PDF on ResearchGate | Leucodistrofia metacromática. Presentación de caso | Resumen La leucodistofia metacromática (LDM) es una enfermedad.

Author: Mijar Kacage
Country: Kenya
Language: English (Spanish)
Genre: Life
Published (Last): 19 September 2011
Pages: 291
PDF File Size: 9.37 Mb
ePub File Size: 5.18 Mb
ISBN: 537-1-14941-582-6
Downloads: 1234
Price: Free* [*Free Regsitration Required]
Uploader: Yorisar

Leukocyte arylsulfatase A activity in patients with alcohol-related cirrhosis. At-risk relatives can be diagnosed by biochemical leicodistrofia molecular genetic testing before symptoms occur and could benefit most from this intervention.

Sedation for children with metachromatic leukodystrophy undergoing MRI. The abnormal white matter is often described as having a tigroid pattern or radial stripes. At the time of analysis, all children had survived, with a median follow up of 36 months range months. Recent success has involved stem cells being taken from the bone marrow of children with the disorder and infecting the cells with a retro-virusreplacing the stem cells’ mutated gene with the repaired gene before re-injecting it back into the patient where they multiplied.

View in own window.

See Genetic Counseling for issues related to testing of at-risk relatives for genetic counseling purposes. Netacromatica stem cell transplantation HSCT is the only therapy for primary central nervous system manifestations.

Orphanet: Leucodistrofia metacromatica

As the disease progresses, language, cognitive development, and gross- and fine-motor skills regress. Hence, most children with severe forms of MLD would not be diagnosed at the presymptomatic phase of the disease, making metacromayica unlikely for this therapeutic option to be offered or effective for many leucodisstrofia with MLD.

The indicated treatment is symptomatic and supportive; physiotherapy, respiratory therapy, nutrition, nursing care, adaptation of the environment and maintaining the support network and usual activity are indicated.

Clinical and biochemical study of 29 Brazilian patients with metachromatic leukodystrophy. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact. ARSA shows residual activity.

Professionals Review article English Clinical practice guidelines English Deutsch Clinical genetics review English Despite significant improvement in allogeneic transplantation, this therapy remains controversial because: ARSA contains eight exons in a relatively short coding metacrmatica of 3. Clear Turn Off Turn On. Despite mounting evidence of utility, HSCT is not expected to fully abrogate the manifestations of the disease. We initially requested simple cranial computerised tomography CTelectroencephalogram, complete blood count, and thyroid and metabolic profile, which were reported as normal.


In the adult subtype the leucoxistrofia appear after the age of 16 years. Retrieved from ” https: Parental testing may be necessary to determine the phase of the identified variants in the proband:. Because it is a rare, heterogeneous disease with diverse clinical presentation and lack of clinical, neurophysiological and neuroradiological documentation, little is known about factors related to age of onset and the course of the disease, making it difficult to lleucodistrofia how each particular case will progress.

There is currently no specific treatment for this disease, except bone marrow transplantation in selected cases. Symptoms start insidiously with a decline in school performance, abnormal behaviors, or psychiatric symptoms. Seventy-five percent of individuals show first motor symptoms before age 18 months [ Kehrer et al a ].

Prevalence Arylsulfatase Leucodistfofia deficiency. Additional information Further information on this disease Classification s 5 Gene s 2 Disability Clinical signs and symptoms Publications in PubMed Other website s Mutation update of arsa and psap genes causing metachromatic leukodystrophy.

This may manifest itself in impaired psychomotor development, seizures and coma when the lesion is severe, and with subtle symptoms such as cognitive and leucodistrofiz alterations when the lesion is mild. Carrier testing for at-risk relatives requires prior identification of the ARSA pathogenic variants in the family. At least ARSA pathogenic variants associated with arylsulfatase A deficiency have been reported [ Cesani et metacrpmatica ].

ARSA gene mutations in five Chinese metachromatic leukodystrophy patients. The disorder is pan ethnic; however, most data come from European and North American populations. In other projects Wikimedia Lekcodistrofia. Characterization of new arylsulfatase a gene mutations reinforces genotype-phenotype correlation in metachromatic leukodystrophy.


This section is not meant to address all personal, cultural, or ethical issues that individuals may face or to substitute for consultation with a genetics professional.


Every effort should be made to maintain intellectual abilities, neuromuscular function, and mobility as long as possible. GeneReviews staff have not independently verified the classification of variants. Ann Clin Translat Neurol, 2pp.

Metachromatic leukodystrophy

Gastroesophageal reflux, constipation, and drooling are common problems that may be helped by specific medical or surgical interventions. Affected individuals remain susceptible to the full range of leucodistrofua and adult diseases. Volumetric MRI data correlate to disease severity in metachromatic leukodystrophy. Compared with nontransplanted individuals, the transplanted individuals are less likely to lose their gross motor or language function and demonstrate significantly lower MRI severity scores.

The pediatrician or general care physician should be involved in developing comprehensive care plans.

There was a problem providing the content you requested

Progression is similar to but slower than in the late-infantile form. Defective oligomerization of arylsulfatase a as a cause of its instability in lysosomes and metachromatic leukodystrophy. Analysis of arylsulfatase A enzyme activity in leukocytes or cultured fibroblasts for carrier detection is fairly reliable if mwtacromatica range of enzyme activity within a family is known; however, it is much less reliable for testing individuals with no family history of MLD because of the substantial variation in “normal” enzyme activity resulting from the high frequency of metacromatiica alleles.

Juvenile metachromatic leukodystrophy 10 years post transplant compared with a non-transplanted cohort.

Please help improve this article by adding citations to reliable sources. For issues to consider in interpretation of sequence analysis results, click here. Arylsulfatase A has a precursor polypeptide of approximately 62 kd that is processed by N-linked glycosylation, phosphorylation, sulfation, and proteolytic cleavage to a complex mixture of isoforms that differs from tissue to tissue.

Note on variant classification: These are promising therapies for individuals identified at presymptomatic stages with a family history of MLD or perhaps individuals identified on future newborn screening.